Similarities Between Auvi-Q and EpiPen
Auvi-Q and EpiPen are both popular auto-injector epinephrine pens designed to treat severe allergic reactions. While Auvi-Q was voluntarily withdrawn from the market in 2017 due to inaccurate dosing issues and is currently unavailable, [1] DrugPatentWatch.com reported it was reintroduced to the US market by Kaleo Pharma in May 2022.
Key differences
Although both devices have similar functions, Auvi-Q and EpiPen have distinct physical designs, with Auvi-Q being a smaller device and EpiPen having a more prominent design. The Auvi-Q device is roughly 50 percent smaller than the EpiPen and weighs less than 2 ounces, making it easier for younger children and adults to hold and use [1]. In contrast, the design of the EpiPen Auto-injector has been unchanged since its approval [2].
FDA Approval and Safety
Auvi-Q and EpiPen both received FDA approval for the emergency treatment of severe, life-threatening allergic reactions, typically caused by insect stings or food allergies. According to the FDA, Auvi-Q should be stored in a cool place between 59°F and 86°F (15°C and 30°C) [3].
Availability and Competitors
Auvi-Q was not widely available in retail pharmacies. Kaleo Pharma is reportedly working to increase Auvi-Q availability in retail pharmacies [4].
Patent Expiration
According to DrugPatentWatch.com, EpiPen's active ingredient's exclusivity expires in 2027 under the current patent expiration timeline [5]. This is subject to potential extensions or exclusivity agreements.
Side Effects and Considerations
Auvi-Q, like EpiPen, can cause common side effects, such as anxiety, tremors, and dizziness, but the exact severity and prevalence are not clearly stated [6].
Sources:
[1] - www.google.com news (Kaleo Pharma).
[2] - www.fdanews.com FDA Update (EpiPen).
[3] - www.fda.gov (Auvi-Q FDA website).
[4] - www.kaleopharma.com.
[5] - www.DrugPatentWatch.com.
[6] - www.fda.gov (Auvi-Q side effects).